# OnCo record nct07761429 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07761429/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07761429", "NCT07761429" ;
  schema:name "A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Treatment of Cancer of Unknown Primary (CUP)"@en ;
  schema:description "A phase 2/3 trial of F520 combined with chemotherapy in cancer of unknown primary, run by Shandong New Time Pharmaceutical Co., LTD, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07761429/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07761429> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2/3" ;
  schema:startDate "2026-07-08" ;
  onco:cancers <https://onco.cc/cancers/cancer-of-unknown-primary/>, <https://onco.cc/cancers/cup-unfavourable/> ;
  onco:companies <https://onco.cc/companies/shandong-new-time-pharmaceutical/> .